Cargando…

Tailored chemotherapy for colorectal cancer peritoneal metastases based on a drug-screening platform in patient-derived organoids: a case report

BACKGROUND: Peritoneal metastasis from colorectal cancer (CRC) has limited therapeutic options and poor prognosis. Systemic chemotherapy combined with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) or pressurized intraperitoneal aerosol chemotherapy (PIPAC) have y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieto, Isabel, Barbáchano, Antonio, Rodríguez-Salas, Nuria, Viñal, David, Cortés-Guiral, Delia, Muñoz, Alberto, Fernández-Barral, Asunción
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007935/ https://www.ncbi.nlm.nih.gov/pubmed/36915469 http://dx.doi.org/10.21037/jgo-22-599

Ejemplares similares

Organoids and Colorectal Cancer
por: Barbáchano, Antonio, et al.
Publicado: (2021)

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
por: Ubink, I., et al.
Publicado: (2019)

Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay
por: Costales-Carrera, Alba, et al.
Publicado: (2019)

Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy
por: López-Rojo, Irene, et al.
Publicado: (2020)

Comparative Study of Organoids from Patient-Derived Normal and Tumor Colon and Rectal Tissue
por: Costales-Carrera, Alba, et al.
Publicado: (2020)

Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases
por: Varinelli, Luca, et al.
Publicado: (2022)

Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?
por: Cortes-Guiral, Delia, et al.
Publicado: (2017)

Urothelial organoids originating from Cd49f(high) mouse stem cells display Notch-dependent differentiation capacity
por: Santos, Catarina P., et al.
Publicado: (2019)

A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Real‐Time Tumor‐Tracking and Photothermal‐Enhanced Chemotherapy
por: Sun, Tao, et al.
Publicado: (2021)

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
por: Hawkes, Eliza A, et al.
Publicado: (2012)

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
por: Cashin, Peter H, et al.
Publicado: (2023)

An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
por: Montero, Juan Carlos, et al.
Publicado: (2023)

Vitamin D Effects on Cell Differentiation and Stemness in Cancer
por: Fernández-Barral, Asunción, et al.
Publicado: (2020)

Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022)

Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance
por: Buzzelli, Jon N., et al.
Publicado: (2018)

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)

Vitamin D differentially regulates colon stem cells in patient‐derived normal and tumor organoids
por: Fernández‐Barral, Asunción, et al.
Publicado: (2019)

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
por: Geevimaan, Khamushavalli, et al.
Publicado: (2022)

Histological regression of gastrointestinal peritoneal metastases after systemic chemotherapy
por: Toussaint, Laura, et al.
Publicado: (2021)

Clinico-Pathological Features, Outcomes and Impacts of COVID-19 Pandemic on Patients with Early-Onset Colorectal Cancer: A Single-Institution Experience
por: Martinez-Perez, Daniel, et al.
Publicado: (2023)

The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2020)

Peritoneal Metastases
por: Yonemura, Yutaka, et al.
Publicado: (2012)

Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival
por: Kwakman, R, et al.
Publicado: (2015)

Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases
por: Somashekhar, SP, et al.
Publicado: (2022)

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy
por: Yonemura, Yutaka, et al.
Publicado: (2013)

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study
por: Cashin, Peter H., et al.
Publicado: (2022)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
por: Witmer, Hunter D. D., et al.
Publicado: (2022)

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
por: Ferrer-Mayorga, Gemma, et al.
Publicado: (2017)

Peritoneal Dialysis Tailored to Pediatric Needs
por: Schmitt, C. P., et al.
Publicado: (2011)

Novel Multi-Modal Therapies and Their Prognostic Potential in Gastric Cancer
por: Chidambaram, Swathikan, et al.
Publicado: (2023)

Tailored Systemic Therapy for Colorectal Cancer Liver Metastases
por: Czauderna, Carolin, et al.
Publicado: (2021)

Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022)

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone
por: Mirnezami, R, et al.
Publicado: (2014)

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
por: Mangieri, Christopher W., et al.
Publicado: (2022)

An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
por: Jiang, Shengwei, et al.
Publicado: (2020)

Detection of peritoneal metastases
por: Healy, Jeremiah C.
Publicado: (2015)

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only
por: Désolneux, Grégoire, et al.
Publicado: (2015)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
por: Turner, Kevin M., et al.
Publicado: (2022)

The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis
por: Flood, Michael P., et al.
Publicado: (2022)

The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
por: Sun, Beatrice J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mphs1h7ef1nkfgaf844vh77g1g